Imago BioSciences, Inc. (IMGO)


0.00 (0.00%)
Symbol IMGO
Price $36.01
Beta 0.000
Volume Avg. 0.76M
Market Cap -
Shares () -
52 Week Range 11.56-36.09
1y Target Est -
DCF Unlevered IMGO DCF ->
DCF Levered IMGO LDCF ->
ROE -25.27% Sell
ROA -25.27% Sell
Operating Margin -
Debt / Equity -
P/E -
P/B 7.04 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest IMGO news

Dr. Hugh Young Rienhoff Jr., M.D.
NASDAQ Global Select

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.